Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03820141
Title Durvalumab With Trastuzumab and Pertuzumab in HER2-Enriched Breast Cancer (DTP)
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors Jenny C. Chang, MD
Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.